In conclusion, oral magnesium supplementation does not improve insulin sensitivity in people with insulin-treated type 2 diabetes and a low magnesium level, neither does it affect glucose control, lipid profile, BP and hypomagnesaemia-related symptoms. The gene discussed is INS; the disease is type 2 diabetes mellitus.